Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Arterioscler Thromb Vasc Biol ; 36(10): 2058-67, 2016 10.
Article in English | MEDLINE | ID: mdl-27562917

ABSTRACT

OBJECTIVE: As they travel through the blood stream, plasma lipoproteins interact continuously with endothelial cells (ECs). Although the focus of research has mostly been guided by the importance of lipoproteins as risk factors for atherosclerosis, thrombosis, and other cardiovascular diseases, little is known about the mechanisms linking lipoproteins and angiogenesis under physiological conditions, and particularly, during embryonic development. In this work, we performed global mRNA expression profiling of endothelial cells from hypo-, and hyperlipidemic zebrafish embryos with the goal of uncovering novel mediators of lipoprotein signaling in the endothelium. APPROACH AND RESULTS: Microarray analysis was conducted on fluorescence-activated cell sorting-isolated fli1:EGFP(+) ECs from normal, hypo-, and hyperlipidemic zebrafish embryos. We found that opposed levels of apoprotein B lipoproteins result in differential expression of the secreted enzyme autotaxin in ECs, which in turn affects EC sprouting and angiogenesis. We further demonstrate that the effects of autotaxin in vivo are mediated by lysophosphatidic acid (LPA)-a well-known autotaxin activity product-and that LPA and LPA receptors participate as well in the response of ECs to lipoprotein levels. CONCLUSIONS: Our findings provide the first in vivo gene expression profiling of ECs facing different levels of plasma apoprotein B lipoproteins and uncover a novel lipoprotein-autotaxin-LPA axis as regulator of EC behavior. These results highlight new roles for lipoproteins as signaling molecules, which are independent of their canonical function as cholesterol transporters.


Subject(s)
Apolipoproteins B/metabolism , Endothelial Cells/enzymology , Hyperlipidemias/enzymology , Lysophospholipids/metabolism , Neovascularization, Physiologic , Phosphoric Diester Hydrolases/metabolism , Zebrafish Proteins/metabolism , Animals , Animals, Genetically Modified , Apolipoproteins B/blood , Apolipoproteins B/genetics , Cell Proliferation , Cells, Cultured , Disease Models, Animal , Gene Expression Profiling/methods , Genotype , Green Fluorescent Proteins/biosynthesis , Green Fluorescent Proteins/genetics , Human Umbilical Vein Endothelial Cells/enzymology , Humans , Hyperlipidemias/blood , Hyperlipidemias/genetics , Lysophospholipids/blood , Mutation , Oligonucleotide Array Sequence Analysis , Phenotype , Phosphoric Diester Hydrolases/blood , Phosphoric Diester Hydrolases/genetics , Receptors, Lysophosphatidic Acid/metabolism , Signal Transduction , Transcription Factors/genetics , Zebrafish/embryology , Zebrafish/genetics , Zebrafish/metabolism , Zebrafish Proteins/blood , Zebrafish Proteins/genetics
2.
Life Sci Alliance ; 3(4)2020 04.
Article in English | MEDLINE | ID: mdl-32132179

ABSTRACT

Angiogenesis and lymphangiogenesis are key processes during embryogenesis as well as under physiological and pathological conditions. Vascular endothelial growth factor C (VEGFC), the ligand for both VEGFR2 and VEGFR3, is a central lymphangiogenic regulator that also drives angiogenesis. Here, we report that members of the highly conserved BACH (BTB and CNC homology) family of transcription factors regulate VEGFC expression, through direct binding to its promoter. Accordingly, down-regulation of bach2a hinders blood vessel formation and impairs lymphatic sprouting in a Vegfc-dependent manner during zebrafish embryonic development. In contrast, BACH1 overexpression enhances intratumoral blood vessel density and peritumoral lymphatic vessel diameter in ovarian and lung mouse tumor models. The effects on the vascular compartment correlate spatially and temporally with BACH1 transcriptional regulation of VEGFC expression. Altogether, our results uncover a novel role for the BACH/VEGFC signaling axis in lymphatic formation during embryogenesis and cancer, providing a novel potential target for therapeutic interventions.


Subject(s)
Basic-Leucine Zipper Transcription Factors/genetics , Fanconi Anemia Complementation Group Proteins/genetics , Neovascularization, Physiologic/physiology , Vascular Endothelial Growth Factor C/genetics , Zebrafish Proteins/genetics , Angiogenesis Modulating Agents/metabolism , Animals , Basic-Leucine Zipper Transcription Factors/metabolism , Cell Line, Tumor , Fanconi Anemia Complementation Group Proteins/metabolism , Female , Gene Expression Regulation, Developmental/genetics , Humans , Lymphangiogenesis/physiology , Lymphatic Vessels/metabolism , Mice , Mice, Inbred C57BL , Mice, Nude , Morphogenesis , Signal Transduction , Vascular Endothelial Growth Factor C/metabolism , Vascular Endothelial Growth Factor Receptor-2/genetics , Vascular Endothelial Growth Factor Receptor-3/genetics , Zebrafish/embryology , Zebrafish Proteins/metabolism
3.
Dis Model Mech ; 8(3): 295-309, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25633982

ABSTRACT

Improved understanding of lipoproteins, particles that transport lipids throughout the circulation, is vital to developing new treatments for the dyslipidemias associated with metabolic syndrome. Apolipoproteins are a key component of lipoproteins. Apolipoproteins are proteins that structure lipoproteins and regulate lipid metabolism through control of cellular lipid exchange. Constraints of cell culture and mouse models mean that there is a need for a complementary model that can replicate the complex in vivo milieu that regulates apolipoprotein and lipoprotein biology. Here, we further establish the utility of the genetically tractable and optically clear larval zebrafish as a model of apolipoprotein biology. Gene ancestry analyses were implemented to determine the closest human orthologs of the zebrafish apolipoprotein A-I (apoA-I), apoB, apoE and apoA-IV genes and therefore ensure that they have been correctly named. Their expression patterns throughout development were also analyzed, by whole-mount mRNA in situ hybridization (ISH). The ISH results emphasized the importance of apolipoproteins in transporting yolk and dietary lipids: mRNA expression of all apolipoproteins was observed in the yolk syncytial layer, and intestinal and liver expression was observed from 4-6 days post-fertilization (dpf). Furthermore, real-time PCR confirmed that transcription of three of the four zebrafish apoA-IV genes was increased 4 hours after the onset of a 1-hour high-fat feed. Therefore, we tested the hypothesis that zebrafish ApoA-IV performs a conserved role to that in rat in the regulation of food intake by transiently overexpressing ApoA-IVb.1 in transgenic larvae and quantifying ingestion of co-fed fluorescently labeled fatty acid during a high-fat meal as an indicator of food intake. Indeed, ApoA-IVb.1 overexpression decreased food intake by approximately one-third. This study comprehensively describes the expression and function of eleven zebrafish apolipoproteins and serves as a springboard for future investigations to elucidate their roles in development and disease in the larval zebrafish model.


Subject(s)
Apolipoproteins A/genetics , Eating/genetics , Zebrafish Proteins/genetics , Zebrafish/genetics , Animals , Apolipoproteins A/metabolism , Apolipoproteins B/genetics , Apolipoproteins B/metabolism , Apolipoproteins E/genetics , Apolipoproteins E/metabolism , Diet, High-Fat , Gene Expression Regulation, Developmental , Intestinal Mucosa/metabolism , Models, Animal , Phylogeny , RNA, Messenger/genetics , RNA, Messenger/metabolism , Transcription, Genetic , Zebrafish/embryology , Zebrafish Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL